Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L12 pseudogene 37 (RPL12P37) is a processed pseudogene in humans, named for its sequence similarity to the functional RPL12 gene, which encodes the 60S ribosomal protein L12[4][5]. Unlike the canonical RPL12 gene, RPL12P37 does not encode a functional protein; it is classified as a pseudogene, meaning it is a remnant of a gene that has lost its protein-coding ability or is otherwise nonfunctional[5]. This pseudogene is annotated in the human genome (NCBI Gene ID: 100129801), with genome location on chromosome 17[5]. Pseudogenes like RPL12P37 do not have established roles as therapeutic targets, do not participate in known molecular signaling, and are not associated with drug interactions, disease roles, or biomarker functions[1][5]. Their main relevance is for genomic annotation and studies of gene family evolution.\n\nClarification: There is nothing misleading in the nomenclature or basic identity, but RPL12P37 is a pseudogene, not a functional protein-coding gene or therapeutic target. This distinguishes it clearly from the functional ribosomal protein L12 (RPL12), which is an essential component of the 60S ribosomal subunit[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 37 (RPL12P37).